Skip to main content

Table 5 The development of non- alcoholic fatty liver disease across quartiles of energy-adjusted daily calcium to magnesium ratio intake

From: Calcium to magnesium intake ratio and non-alcoholic fatty liver disease development: a case-control study

  Energy-adjusted daily calcium to magnesium ratio intake
Q1(n = 250) Q2(n = 249) P-value* Q3(n = 250) P-value* Q4(n = 250) P-value*
Cases/control 27/223 34/215   49/201   86/164  
Range of Ca to Mg ratio 0.95 to 1.97 1.97 to 2.36   2.36 to 2.81   2.82 to 5.02  
aModel 1 1 (Ref) 1.30
(0.76–2.23)
0.33 2.01
(1.21–3.34)
0.007 4.33
(2.68–6.97)
< 0.001
bModel 2 1 (Ref) 1.22
(0.71–2.11)
0.46 1.93
(1.15–3.21)
0.012 4.45
(2.75–7.21)
< 0.001
cModel 3 1 (Ref) 1.57
(0.73–3.35)
0.24 2.89
(1.35–6.16)
0.006 5.72
(2.82–11.60)
< 0.001
dModel 4 1 (Ref) 1.82
(0.76–4.37)
0.17 2.86
(1.20–6.81)
0.017 5.97
(2.54–14.01)
< 0.001
  1. Data are presented as odds ratio (95 %CI)
  2. *Logistic regression
  3. acrude model
  4. bAdjusted for age and gender
  5. cAdditionally adjusted for body mass index, alcohol consumption, smoking, diabetes and physical activity
  6. dAdditionally adjusted for energy, dietary fiber, carbohydrate, fat, and protein intakes
  7. The significance level: P < 0.05